Thomas C. King
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 8
- Cancer-related Molecular Pathways 4
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
- Molecular Biology top 10%
- RNA and protein synthesis mechanisms 11
-
- Hormonal Regulation and Hypertension 4
-
- Lymphoma Diagnosis and Treatment 5
-
- Chronic Lymphocytic Leukemia Research 4
-
- Innovations in Medical Education 4
- Co-authors
- David SchlessingerHoward SafranRobert L. LowAndrew S. BremDavid J. MorrisPingfu FengJeffrey MilbrandtPaul S. Changelian
- Journals
- Journal of Biological Chemistry (6 papers)The American Journal of Surgery (4 papers)American Journal of Clinical Pathology (4 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Thomas C. King
86 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 127
- Oncology 644
- Cancer Research 344
- Molecular Biology 924
- Endocrinology, Diabetes and Metabolism 192
- Critical Care and Intensive Care Medicine 57
Countries citing papers authored by Thomas C. King
This map shows the geographic impact of Thomas C. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. King more than expected).
Fields of papers citing papers by Thomas C. King
This network shows the impact of papers produced by Thomas C. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. King. The network helps show where Thomas C. King may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas C. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2016 | 1 | |
| 3 | 2015 | 24 | |
| 4 | 2015 | 39 | |
| 5 | 2015 | 15 | |
| 6 | 2013 | 8 | |
| 7 | 2007 | 82 | |
| 8 | 2001 | 62 | |
| 9 | 2001 | 134 | |
| 10 | 1999 | 14 | |
| 11 | 1998 | 25 | |
| 12 | 1996 | 40 | |
| 13 | 1995 | 6 | |
| 14 | 1995 | 51 | |
| 15 | 1995 | 5 | |
| 16 | 1990 | 4 | |
| 17 | 1988 | 32 | |
| 18 | 1965 | 15 | |
| 19 | 1965 | 3 | |
| 20 | 1964 | 4 |
About Thomas C. King
Thomas C. King is a scholar working on Oncology, Dermatology, Genetics, Cancer Research and Surgery, having authored 91 papers that have together received 2.5k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (11 papers), Pancreatic and Hepatic Oncology Research (8 papers), Cancer Genomics and Diagnostics (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer-related Molecular Pathways (4 papers), Hormonal Regulation and Hypertension (4 papers) and Innovations in Medical Education (4 papers). The work is most often cited by research in Oncology (644 citations), Cancer Research (344 citations), Molecular Biology (924 citations), Endocrinology, Diabetes and Metabolism (192 citations) and Critical Care and Intensive Care Medicine (57 citations). Thomas C. King has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include David Schlessinger, Howard Safran, Robert L. Low, Andrew S. Brem, David J. Morris, Pingfu Feng, Jeffrey Milbrandt, Paul S. Changelian, Kojo S.J. Elenitoba‐Johnson and Oscar C Estalilla. Their work appears in journals such as Journal of Biological Chemistry, The American Journal of Surgery, American Journal of Clinical Pathology, The American Journal of Surgical Pathology and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.